pharma
dog
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
News
when
Latest
Archive
by source
All Sources
Sources Page
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
48
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
(cilnidipine + tadalafil)
(cilnidipine [INN] + tadalafil)
Systemic Sclerosis (Scleroderma)
AISA Pharma Inc
0
catalysts
Phase 2
AB-002
Thrombosis
Lysyl oxidase homolog 2
Aronora Inc
0
catalysts
Phase 2
ACP-01
Vescell
Chronic Stable Angina
Hemostemix Inc
0
catalysts
← prev
page 1 of 2
next →
131
Pain
89
Neurology
1
Phase 2
AFTX-201
Dilated Cardiomyopathy
Affinia Therapeutics Inc
0
catalysts
Phase 2
BGC-101
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD)
BiogenCell Ltd
0
catalysts
Phase 2
CST-3056
Neurogenic Orthostatic Hypotension (nOH)
CuraSen Therapeutics Inc
0
catalysts
Phase 2
CardiALLO
Systolic Heart Failure (HFrEF)
$BCDA
BioCardia, Inc.
0
catalysts
Phase 2
Carfostin
Non-ischemic Cardiomyopathy
Asklepios BioPharmaceutical Inc
0
catalysts
Phase 2
DF-003
Chronic Kidney Disease (Chronic Renal Failure)
Drug Farm Inc
0
catalysts
Phase 2
FGF-1
Coronary Artery Disease (CAD) (Ischemic Heart Disease)
Zhittya Genesis Medicine Inc
0
catalysts
Phase 2
GP-531
Congestive Heart Failure (Heart Failure)
ViCardia Therapeutics Inc
0
catalysts
Phase 2
HBI-3000
Atrial Fibrillation
HUYA Bioscience International LLC
0
catalysts
Phase 2
HUNS-001
Cerebral Infarction (Brain Infarction)
Rainbow Inc
0
catalysts
Phase 2
HeXell-2020
Coronary Artery Disease (CAD) (Ischemic Heart Disease)
Hexun Bioscience Co Ltd
0
catalysts
Phase 2
JK-07
Diastolic Heart Failure (HFpEF)
Salubris Biotherapeutics Inc
0
catalysts
Phase 2
LX-2006
Cardiomyopathy
$LXEO
Lexeo Therapeutics, Inc.
0
catalysts
Phase 2
LX-2020
Cardiomyopathy
$LXEO
Lexeo Therapeutics, Inc.
0
catalysts
Phase 2
MANP
Resistant Hypertension
E-Star BioTech LLC
0
catalysts
Phase 2
Motrem
Septic Shock
Triggering receptor expressed on myeloid cells 1
Inotrem SA
0
catalysts
Phase 2
Mydicar
Systolic Heart Failure (HFrEF)
Sardocor Corp
0
catalysts
Phase 2
NCS-01
Acute Ischemic Stroke
NC Medical Research Inc
0
catalysts
Phase 2
NVX-108
perflenapent
Glioblastoma Multiforme (GBM)
NuvOx Pharma LLC
0
catalysts
Phase 2
NovoCardia
Congestive Heart Failure (Heart Failure)
Help Therapeutics
0
catalysts
Phase 2
PF-07868489
Pulmonary Arterial Hypertension
$PFE
PFIZER INC
0
catalysts
Phase 2
PKN-605
Atrial Fibrillation
$NVS
NOVARTIS AG
0
catalysts
Phase 2
PR-15
Stroke
advanceCor GmbH
0
catalysts
Phase 2
RNS-60
Acute Ischemic Stroke
Revalesio Corp
0
catalysts
Phase 2
RT-100
Systolic Heart Failure (HFrEF)
Renova Therapeutics Inc
0
catalysts
Phase 2
ReversPAH
Pulmonary Arterial Hypertension
Artin Bioscience Inc
0
catalysts
Phase 2
SCP-776
Acute Ischemic Stroke
Silver Creek Pharmaceuticals Inc
0
catalysts
